Chapter 3

Ownership and Governance

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates (roughly ₹1 = $0.0117 for FY2024-25 and $0.0111 for FY2026/current). Ratios, margins, multiples, share counts, and percentages are unitless and unchanged.

Nuvama has never had a permanent owner. Control passed from the Edelweiss group to the private-equity firm PAG in 2020, and PAG — sitting on roughly a five-fold paper gain — is now in advanced talks to sell its ~54.8% stake to another financial sponsor, General Atlantic [1]. There is no founder in the register and no manager with a controlling stake. Governance itself is institutionally clean; the alignment a value investor screens for — durable, founder-style skin in the game — is simply not the model here.

A company that changes hands, not owners

The controlling stake in the wealth business was carved out of Edelweiss and bought by PAG in 2020 for about $325m [2]. PAG became the promoter, the business was demerged and listed in September 2023, and as of 31 March 2025 two PAG-controlled entities held 19,707,345 shares, or 54.78% of the company [3]. At the September 2023 listing the same promoter block was 55.29% [4]; the small drift down since is dilution from employee-option exercises, not a PAG selldown.

In June 2026, reports placed General Atlantic in advanced talks to buy PAG's ~54% controlling stake for about $1.82bn, with Morgan Stanley and JPMorgan advising, the process reportedly slowed by a valuation gap after the stock's rally [5]. Two implications matter for a prospective public shareholder. First, a change of control above the SEBI takeover threshold triggers a mandatory open offer to public holders for up to 26% of the company — an exit option at the offer price, but also confirmation that the buyer sets the reference mark, not the screen. Second, the reported ~$1.82bn for ~54.8% implies a whole-company value near $3.4bn, below the market capitalisation the shares carried in mid-2026 — the same gap flagged in What Nuvama Is, now with a named counterparty attached to it.

Source: compiled news, June–July 2026 [6]; FY2024-25 Annual Report, Shareholding Details [7].

Who owns the other 45%

Outside PAG, the register is institutional and dispersed. As of 31 March 2025, foreign portfolio investors held ~16.6%, mutual funds 4.6%, insurers and alternative funds another ~1.2%, domestic bodies corporate 3.3%, and retail-scale public holders 17.5% [8]. There is no second promoter, no founding family, and no employee trust of any size — the entire ~45.2% free float sits with financial investors.

Source: FY2024-25 Annual Report, Corporate Governance Report — Shareholding Details [9]. "Insurers, AIFs and other" groups insurance companies, AIF-III, HUFs, NRIs and trusts.

For a value investor who hunts fallen stars with strong insider ownership, this is the structural fact to sit with: the people running Nuvama do not, as a group, control it, and the people who control it are in the business of selling. That is not a governance defect — it is a different alignment model, and one worth naming plainly rather than scoring against a founder-owned template.

Management is aligned by pay and options, not by ownership

Ashish Kehair has led Nuvama as Managing Director and CEO since September 2021; Shiv Sehgal runs Capital Markets as Executive Director. Neither founded the business, and both are aligned the way professional managers of a sponsor-owned firm usually are — through cash-weighted variable pay and equity-settled options, not a controlling shareholding.

Source: FY2024-25 Annual Report, Corporate Governance Report — remuneration of Executive Directors [10]. Excludes one-time LTIP payouts ($0.29m Kehair; $0.17m Sehgal) granted in FY2021-22.

Kehair's FY25 package totalled about $1.13m, roughly two-thirds of it variable pay, with a one-time legacy LTIP of about $0.29m on top; Sehgal's totalled about $0.85m [11]. The CEO's pay ran at about 47 times the median employee's — high in absolute terms but not extreme for a capital-markets firm, and heavily performance-geared rather than fixed.

The equity link runs through options. Under the ESOP 2021 and SAR 2024 plans, about 1.91 million options and appreciation rights were outstanding at 31 March 2025 — near 5.3% of the then 35.97 million shares, though the appreciation rights settle only the gain, so net issuance is smaller [12]. The ESOP strike of about $15 sits deep in the money against a share price in the tens of dollars before the December 2025 split; the plans have been a genuine wealth event for senior staff [13]. Share-based-payment expense was modest against profit — about $3.7 million consolidated in FY25 — so the drag on earnings is small; the question is dilution and its timing, not the cost [14].

That timing is now live. In July 2026 the company put a fresh ESAR 2026 scheme — up to 1.37 crore rights — plus revised remuneration for Kehair and Sehgal to a postal ballot [15]. A large new employee-incentive pool and higher executive pay, arriving as control is about to change hands, is the kind of item a governance-minded reader tracks: it re-aligns the team a new sponsor will inherit, and it dilutes the public shareholder at the margin.

The governance framework itself holds up

Where the ownership model is unusual, the governance scaffolding is conventional and compliant. At the FY25 report date the board had eight directors: an independent non-executive chairperson, three other independent directors, two PAG nominees, and two executives — a majority non-executive board with the chair and CEO roles separated, a discretionary best practice the company adopted [16], each director's category set out in the board table [17]. The audit committee is chaired by an independent director, the statutory auditor (S.R. Batliboi & Co. LLP) issued an unmodified opinion, and the company reported no material related-party transactions in FY25 — all in the ordinary course and at arm's length [18].

Two textures are worth holding. Board turnover has been steady around the ownership question — two nominee directors and one independent director resigned across FY24–FY25, and a long-serving independent director's second term was set to end in April 2026 — so the board a new sponsor inherits is already in flux [19]. And the Edelweiss lineage lingers in the boardroom: an independent director also sits on Edelweiss-group boards such as ECL Finance and Edelweiss Asset Reconstruction [20]. Neither rises to a red flag on the record, but both are worth watching through the transition.

The solvency gate

This reader excludes companies that could go bankrupt, so the balance sheet earns a direct check. Nuvama is a leveraged financial — net debt was about $1.22bn against equity of about $459m at FY26, a debt-to-equity ratio near 2.8x, funding a margin-lending and clearing book rather than an operating deficit. What offsets the leverage is profitability and rating. Return on equity has run 22–28% over FY24–FY26, equity is compounding in the high teens to low twenties, and every rating agency carries the company at AA– — CRISIL and CARE at AA–/Stable with A1+ short-term, and ICRA at AA– with its outlook raised to Positive in FY25 [21].

Source: return on equity and debt/equity derived from reported financials, FY2024-26 [22]; credit ratings per FY2024-25 Annual Report.

An AA– issuer earning a mid-20s ROE is not a bankruptcy candidate on the current record. The genuine risk is second-order: the leverage funds a lending and clearing book whose quality through a severe drawdown is not yet tested at this size — a thread the report should still pull separately, since the rating agencies rate the entity, not any single stressed scenario.

What this means for a margin-of-safety buyer

On the specific screen this reader uses — a fallen star with strong founder or insider ownership — Nuvama does not fit. It is near record levels, not fallen; it is controlled by a private-equity seller, not a founder-owner; and management's stake is an option package, not a controlling holding. The offsetting evidence is real and should be weighed in the same breath: governance is clean and compliant, related-party dealings are immaterial, the balance sheet is investment-grade, and management does hold quarterly calls with the CEO presenting — the engagement discipline this reader values. What would change the read is the deal itself: General Atlantic's final price and structure would set an arm's-length mark for the whole company, and a founder-style lock-in or a sponsor committed to a longer hold would narrow the ownership gap that the screen, on today's facts, leaves open.